These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7515264)

  • 1. Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.
    Walker RA; Dearing SJ; Gallacher B
    Br J Cancer; 1994 Jun; 69(6):1160-5. PubMed ID: 7515264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast.
    Walker RA; Dearing SJ
    Eur J Cancer; 1992; 28(2-3):641-4. PubMed ID: 1317202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
    Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
    Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
    Gould VE; Koukoulis GK; Virtanen I
    Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
    Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
    J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro.
    Sakai T; Kawakatsu H; Ohta M; Saito M
    J Cell Physiol; 1994 Jun; 159(3):561-72. PubMed ID: 7514613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
    Jones JL; Critchley DR; Walker RA
    J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of tenascin and fibronectin in odontogenic tumours and human fetal tooth germs.
    Nagai N; Yamachika E; Nishijima K; Inoue M; Shin HI; Suh MS; Nagatsuka H
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):191-5. PubMed ID: 7522711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
    Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
    Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of transforming growth factor beta, fibronectin, and fibronectin receptor in invasive mammary carcinomas.
    Oda K; Hori S; Itoh H; Osamura RY; Tokuda Y; Kubota M; Tajima T
    Acta Pathol Jpn; 1992 Sep; 42(9):645-50. PubMed ID: 1476059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
    Shoji T; Kamiya T; Tsubura A; Hamada Y; Hatano T; Hioki K; Morii S
    J Surg Res; 1993 Sep; 55(3):295-7. PubMed ID: 7692137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
    Hazelbag S; Gorter A; Kenter GG; van den Broek L; Fleuren G
    Hum Pathol; 2002 Dec; 33(12):1193-9. PubMed ID: 12514788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin and fibronectin distribution in human normal and pathological synovium.
    Cutolo M; Picasso M; Ponassi M; Sun MZ; Balza E
    J Rheumatol; 1992 Sep; 19(9):1439-47. PubMed ID: 1279171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study].
    Yano S
    Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing patterns of transforming growth factor-beta expression in normal intestinal mucosa and in active celiac disease.
    Lionetti P; Pazzaglia A; Moriondo M; Azzari C; Resti M; Amorosi A; Vierucci A
    J Pediatr Gastroenterol Nutr; 1999 Sep; 29(3):308-13. PubMed ID: 10467997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of tenascin, laminin and fibronectin following traumatic rupture of the anterior cruciate ligament].
    Neurath M
    Z Orthop Ihre Grenzgeb; 1993; 131(2):168-72. PubMed ID: 7685136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
    Kong FM; Anscher MS; Murase T; Abbott BD; Iglehart JD; Jirtle RL
    Ann Surg; 1995 Aug; 222(2):155-62. PubMed ID: 7543740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
    Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
    Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
    Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
    Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.